Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing
- Rock-Tenn (RKT), MeadWestvaco (MWV) Enter $16B Merger Agreement
- Energy Transfer (ETP), Regency Energy (RGP) Enter $18B Merger Agreement
- Pre-Open Stock Movers 01/26: (OCN) (OLED) (RGP) (MWV) Higher; (MAT) (STX) (PRE) (Lower (more...)
- FXCM, Inc. (FXCM) Issues Update on Month-to-Date Retail Trading Volume, Deal with Leucadia (LUK)
- Ocwen Financial (OCN) Surges Following Settlement with California
Zogenix (Nasdaq: ZGNX) Zohydro ER fails to win FDA panel backing.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rockwell Medical Technologies (RMTI) Receives FDA Approval of Triferic
- Home Loan Servicing Solutions (HLSS) Will Defend Itself Against BlueMountain Capital Allegations
- BioCryst Pharma (BCRX) Receives FDA Fast-Track Designation for BCX4161
Create E-mail Alert Related CategoriesCorporate News, FDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!